CHR Metz-Thionville/Hopital de Mercy
Metz, 57085, France
NCT Number: NCT05788523
Dyskalemia, hypo- and hyperkalemia are common in the emergency department and are associated with increased morbidity and mortality.
The potential seriousness of dyskalemia results from the potential alteration of intracardiac conduction and the increase in cardiac rhythm disorders, all associated with a lethal risk. Given the aspecific symptoms of dyskalemia and the complex causal links to be acquired, it is difficult to judge the severity of the disorders in front of an initial clinical presentation of a patient in the emergency room, as the patient may present a serious condition during his stay in the emergency room, related to the dyskalemia and not prejudged at first. The ECG is recommended to judge the severity of the disorder, in association with the level of kalemia, but the electrical changes of its pattern in the context of dyskalemia are sometimes so fine that even the eye of the practitioner is not able to detect them. To date and to our knowledge, there is no tool for predicting the risk of RTA or death in dyskalemia. The existing studies on the subject, including ECGs, seek to detect dyskalemia and not its complications, and the proposed tools only take into account the ECG and not the clinical context of the patient.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Metz, 57085, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: within 48 hours
Number of patients with Cardiac arrest and/or rhythm disorder within 48 hours of the ED visit
Time frame: within 48 hours
Rate of Mortality : all causes combined (SAU, hospitalization, SMUR, home)
Time frame: within 48 hours
The type of treatment received for dyskalemia (IV and what type, orally and what type)
Centre Hospitalier Régional Metz-Thionville
Other
Acronym: PODKA-R
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04497922
Behavior, COVID-19
Boston, Massachusetts, United States
View Trial DetailsNCT04916028
Chemically-Induced Disorders, Disease Attributes
Amiens, France
View Trial DetailsNCT04031183
Disease Attributes, Emergencies
Angers, France
View Trial DetailsNCT03107260
Cerebral Saturation, Cognition Disorders
Amiens, Picardie, France
View Trial Details